Biocompatible hyperbranched polyglycerol modified ß-cyclodextrin derivatives for docetaxel delivery

© 2016 Elsevier B.V. The development of biocompatible vector for hydrophobic drug delivery remains a longstanding issue in cancer therapy. We design and synthesis a drug delivery system based on HPG modified ß-CD (ß-CD-HPG) by conjugating HPG branches onto ß-CD core and its structure was confirmed b...

Full description

Bibliographic Details
Main Authors: Xu, Z., Zhang, Y., Hu, Q., Tang, Q., Xu, J., Wu, Jian-Ping, Kirk, T., Ma, D., Xue, W.
Format: Journal Article
Published: Elsevier 2017
Online Access:http://hdl.handle.net/20.500.11937/55136
_version_ 1848759544403984384
author Xu, Z.
Zhang, Y.
Hu, Q.
Tang, Q.
Xu, J.
Wu, Jian-Ping
Kirk, T.
Ma, D.
Xue, W.
author_facet Xu, Z.
Zhang, Y.
Hu, Q.
Tang, Q.
Xu, J.
Wu, Jian-Ping
Kirk, T.
Ma, D.
Xue, W.
author_sort Xu, Z.
building Curtin Institutional Repository
collection Online Access
description © 2016 Elsevier B.V. The development of biocompatible vector for hydrophobic drug delivery remains a longstanding issue in cancer therapy. We design and synthesis a drug delivery system based on HPG modified ß-CD (ß-CD-HPG) by conjugating HPG branches onto ß-CD core and its structure was confirmed by NMR, FTIR, GPC and solubility. In vitro biocompatibility tests showed that HPG modification significantly improved red blood cells morphology alteration and hemolysis cause by ß-CD and ß-CD-HPG displayed cell safety apparently in a wide range of 0.01–1 mg/mL. An anti-cancer drug, docetaxel, was effectively encapsulated into ß-CD-HPG which wa s confirmed by DSC analysis. This copolymer could form nanoparticles with small size ( < 200 nm) and exhibited better DTX loading capacity and controlled release kinetics without initial burst release behavior compared with ß-CD. Furthermore, antitumor assay in vitro show that ß-CD-HPG/DTX effectively inhibited proliferation of human breast adenocarcinoma cells. Therefore, ß-CD-HPG/DTX exhibit great potential for cancer chemotherapy.
first_indexed 2025-11-14T10:01:34Z
format Journal Article
id curtin-20.500.11937-55136
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T10:01:34Z
publishDate 2017
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-551362017-09-13T16:10:06Z Biocompatible hyperbranched polyglycerol modified ß-cyclodextrin derivatives for docetaxel delivery Xu, Z. Zhang, Y. Hu, Q. Tang, Q. Xu, J. Wu, Jian-Ping Kirk, T. Ma, D. Xue, W. © 2016 Elsevier B.V. The development of biocompatible vector for hydrophobic drug delivery remains a longstanding issue in cancer therapy. We design and synthesis a drug delivery system based on HPG modified ß-CD (ß-CD-HPG) by conjugating HPG branches onto ß-CD core and its structure was confirmed by NMR, FTIR, GPC and solubility. In vitro biocompatibility tests showed that HPG modification significantly improved red blood cells morphology alteration and hemolysis cause by ß-CD and ß-CD-HPG displayed cell safety apparently in a wide range of 0.01–1 mg/mL. An anti-cancer drug, docetaxel, was effectively encapsulated into ß-CD-HPG which wa s confirmed by DSC analysis. This copolymer could form nanoparticles with small size ( < 200 nm) and exhibited better DTX loading capacity and controlled release kinetics without initial burst release behavior compared with ß-CD. Furthermore, antitumor assay in vitro show that ß-CD-HPG/DTX effectively inhibited proliferation of human breast adenocarcinoma cells. Therefore, ß-CD-HPG/DTX exhibit great potential for cancer chemotherapy. 2017 Journal Article http://hdl.handle.net/20.500.11937/55136 10.1016/j.msec.2016.11.005 Elsevier restricted
spellingShingle Xu, Z.
Zhang, Y.
Hu, Q.
Tang, Q.
Xu, J.
Wu, Jian-Ping
Kirk, T.
Ma, D.
Xue, W.
Biocompatible hyperbranched polyglycerol modified ß-cyclodextrin derivatives for docetaxel delivery
title Biocompatible hyperbranched polyglycerol modified ß-cyclodextrin derivatives for docetaxel delivery
title_full Biocompatible hyperbranched polyglycerol modified ß-cyclodextrin derivatives for docetaxel delivery
title_fullStr Biocompatible hyperbranched polyglycerol modified ß-cyclodextrin derivatives for docetaxel delivery
title_full_unstemmed Biocompatible hyperbranched polyglycerol modified ß-cyclodextrin derivatives for docetaxel delivery
title_short Biocompatible hyperbranched polyglycerol modified ß-cyclodextrin derivatives for docetaxel delivery
title_sort biocompatible hyperbranched polyglycerol modified ß-cyclodextrin derivatives for docetaxel delivery
url http://hdl.handle.net/20.500.11937/55136